Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of the Minto Model in Effect Site Mode for Target Controlled Infusion of Remifentanil During Cardiopulmonary Bypass

NCT02566733 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02566733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02566733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of the Minto Model in Effect Site Mode for Target Controlled Infusion of Remifentanil During Cardiopulmonary Bypass
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2015
Completion date
June 30, 2016
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthetics, anesthetics, intravenous, cardiopulmonary bypass, pharmacology